Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10858359 Heterocyclic ring derivatives useful as SHP2 inhibitors
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 20 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10858359
0
0
Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 29 Apr, 2023
Infobox
Patent Citations
US Patent 10463662 Non-platinum-based anti-cancer compounds for use in targeted chemotherapy
0
"update citations for inverse infoboxes"
Golden AI
edited on 29 Apr, 2023
Infobox
Patent Citations
US Patent 10253046 TYK2 inhibitors and uses thereof
0
Edits on 6 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 6 Apr, 2023
Infobox
Patent Citations
US Patent 10287266 Compounds and compositions for inhibiting the activity of SHP2
0
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 2 Apr, 2023
Infobox
Patent Citations
US Patent 10301278 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2
0
Edits on 31 Mar, 2023
"Entity importer update"
Golden AI
edited on 31 Mar, 2023
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10858359
0
Date of Patent
December 8, 2020
0
Patent Application Number
16307827
0
Date Filed
June 7, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10858359
0
Patent Citations
US Patent 10077276 N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
0
US Patent 10253046 TYK2 inhibitors and uses thereof
0
US Patent 10287266 Compounds and compositions for inhibiting the activity of SHP2
0
US Patent 10301278 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2
0
US Patent 10329270 Heteroaryl compounds as BTK inhibitors and uses thereof
0
US Patent 10377742 AMPK-activating heterocyclic compounds and methods for using the same
0
US Patent 10463662 Non-platinum-based anti-cancer compounds for use in targeted chemotherapy
0
Patent Citations Received
US Patent 10988466 Heterocyclic derivatives useful as SHP2 inhibitors
0
Patent Primary Examiner
John S Kenyon
0
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 28 Mar, 2023
Infobox
Patent Citations Received
US Patent 10988466 Heterocyclic derivatives useful as SHP2 inhibitors
0
Edits on 23 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 23 Mar, 2023
Infobox
Patent Citations
US Patent 10329270 Heteroaryl compounds as BTK inhibitors and uses thereof
0
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 27 Sep, 2022
Infobox
Patent Citations
US Patent 10377742 AMPK-activating heterocyclic compounds and methods for using the same
0
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10858359
0
Date of Patent
December 8, 2020
0
Patent Application Number
16307827
0
Date Filed
June 7, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10858359
0
Patent Citations
US Patent 10077276 N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
0
US Patent 10253046 TYK2 inhibitors and uses thereof
0
US Patent 10287266 Compounds and compositions for inhibiting the activity of SHP2
0
US Patent 10301278 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2
0
US Patent 10329270 Heteroaryl compounds as BTK inhibitors and uses thereof
0
US Patent 10377742 AMPK-activating heterocyclic compounds and methods for using the same
0
US Patent 10463662 Non-platinum-based anti-cancer compounds for use in targeted chemotherapy
0
Patent Citations Received
US Patent 10988466 Heterocyclic derivatives useful as SHP2 inhibitors
0
Patent Primary Examiner
John S Kenyon
0
"update citations for inverse infoboxes"
Golden AI
edited on 25 Sep, 2022
Infobox
Patent Citations
US Patent 10077276 N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
0
Edits on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 24 Sep, 2022
Infobox
Patent Citations
US Patent 10329270 Heteroaryl compounds as BTK inhibitors and uses thereof
0
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 22 Sep, 2022
Infobox
Patent Citations
US Patent 10301278 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2
0
"update citations for inverse infoboxes"
Golden AI
edited on 22 Sep, 2022
Infobox
Patent Citations
US Patent 10253046 TYK2 inhibitors and uses thereof
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10858359
Edits on 11 Feb, 2022
"update inverses"
Golden AI
edited on 11 Feb, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent citations received
US Patent 10988466 Heterocyclic derivatives useful as SHP2 inhibitors
Edits on 8 Feb, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 8 Feb, 2022
Edits made to:
Infobox
(
+14
properties)
US Patent 10858359 Heterocyclic ring derivatives useful as SHP2 inhibitors
Infobox
Is a
Patent
Patent jurisdiction
United States Patent and Trademark Office
Patent number
10858359
Date of patent
December 8, 2020
Patent application number
16307827
Date Filed
June 7, 2017
Patent citations
US Patent 10077276 N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
US Patent 10253046 TYK2 inhibitors and uses thereof
US Patent 10287266 Compounds and compositions for inhibiting the activity of SHP2
US Patent 10301278 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2
US Patent 10329270 Heteroaryl compounds as BTK inhibitors and uses thereof
US Patent 10377742 AMPK-activating heterocyclic compounds and methods for using the same
US Patent 10463662 Non-platinum-based anti-cancer compounds for use in targeted chemotherapy
Patent primary examiner
John S Kenyon
Find more entities like US Patent 10858359 Heterocyclic ring derivatives useful as SHP2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE